TD Private Client Wealth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5K | Sell |
221
-8,311
| -97% | -$1.26M | ﹤0.01% | 905 |
|
|
2025
Q1 | $1.28M | Sell |
8,532
-490
| -5% | -$73.8K | 0.04% | 296 |
|
|
2024
Q4 | $1.67M | Sell |
9,022
-320
| -3% | -$59.1K | 0.05% | 259 |
|
|
2024
Q3 | $1.84M | Sell |
9,342
-2,883
| -24% | -$568K | 0.05% | 257 |
|
|
2024
Q2 | $2.53M | Sell |
12,225
-24
| -0.2% | -$4.96K | 0.08% | 191 |
|
|
2024
Q1 | $3.32M | Buy |
12,249
+2,612
| +27% | +$708K | 0.11% | 149 |
|
|
2023
Q4 | $2.28M | Sell |
9,637
-263
| -3% | -$62.2K | 0.08% | 194 |
|
|
2023
Q3 | $1.94M | Sell |
9,900
-744
| -7% | -$146K | 0.08% | 209 |
|
|
2023
Q2 | $2.24M | Sell |
10,644
-55
| -0.5% | -$11.6K | 0.1% | 205 |
|
|
2023
Q1 | $2.16M | Sell |
10,699
-342
| -3% | -$69K | 0.1% | 209 |
|
|
2022
Q4 | $2.41M | Sell |
11,041
-1,559
| -12% | -$340K | 0.11% | 186 |
|
|
2022
Q3 | $2.48M | Sell |
12,600
-300
| -2% | -$59K | 0.13% | 167 |
|
|
2022
Q2 | $2.76M | Sell |
12,900
-714
| -5% | -$153K | 0.13% | 163 |
|
|
2022
Q1 | $3.87M | Buy |
13,614
+1,389
| +11% | +$394K | 0.16% | 136 |
|
|
2021
Q4 | $4.61M | Sell |
12,225
-635
| -5% | -$239K | 0.19% | 117 |
|
|
2021
Q3 | $5.31M | Buy |
12,860
+6
| +0% | +$2.48K | 0.23% | 96 |
|
|
2021
Q2 | $4.75M | Sell |
12,854
-6,844
| -35% | -$2.53M | 0.2% | 108 |
|
|
2021
Q1 | $5.71M | Sell |
19,698
-119
| -0.6% | -$34.5K | 0.27% | 86 |
|
|
2020
Q4 | $4.95M | Buy |
19,817
+624
| +3% | +$156K | 0.25% | 91 |
|
|
2020
Q3 | $4.35M | Sell |
19,193
-290
| -1% | -$65.7K | 0.24% | 90 |
|
|
2020
Q2 | $3.4M | Buy |
19,483
+1,768
| +10% | +$308K | 0.2% | 112 |
|
|
2020
Q1 | $2.24M | Sell |
17,715
-978
| -5% | -$123K | 0.16% | 133 |
|
|
2019
Q4 | $2.86M | Buy |
+18,693
| New | +$2.86M | 0.17% | 141 |
|